Free Trial
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

Ampio Pharmaceuticals logo
$0.0006 0.00 (0.00%)
As of 03/28/2025

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Key Stats

Today's Range
$0.0006
$0.0006
50-Day Range
N/A
52-Week Range
$0.00
$1.05
Volume
2 shs
Average Volume
475 shs
Market Capitalization
$681.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Remove Ads
Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Stock News Headlines

Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com
Trump’s Great Society
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Ampio Pharmaceuticals, Inc. (AMPE)
See More Headlines

AMPE Stock Analysis - Frequently Asked Questions

Ampio Pharmaceuticals' stock was trading at $0.0026 at the beginning of the year. Since then, AMPE stock has decreased by 76.9% and is now trading at $0.0006.
View the best growth stocks for 2025 here
.

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.40) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.40).

Ampio Pharmaceuticals shares reverse split on Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ampio Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Trevena (TRVN), General Electric (GE) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/10/2021
Today
3/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:AMPE
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.00

Miscellaneous

Free Float
1,098,000
Market Cap
$681.00
Optionable
No Data
Beta
3.77
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:AMPE) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners